Matrix metalloproteinases and acute aortic dissection: Et Tu, Brute?

Hisato Takagi1,2, Yosuke Hari1,2, Kouki Nakashima1,2

  • 1Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.

Abstract

Insights

This meta-analysis found that matrix metalloproteinase-9 (MMP-9) levels are significantly higher in acute aortic dissection (AAD) patients. Elevated MMP-8 and MMP-12 may also be associated with AAD.

Area of Science:

  • Cardiovascular Research
  • Biomarkers
  • Medical Diagnostics

Background:

  • Matrix metalloproteinases (MMPs) play a role in extracellular matrix remodeling.
  • Alterations in MMP levels have been implicated in various cardiovascular diseases.
  • Acute aortic dissection (AAD) is a life-threatening condition with complex pathophysiology.

Purpose of the Study:

  • To synthesize current evidence on the association between circulating matrix metalloproteinases (MMPs) and acute aortic dissection (AAD).
  • To conduct the first meta-analysis comparing MMP levels in AAD patients versus control subjects.

Main Methods:

  • A systematic literature search was conducted on PubMed and Web of Science up to July 2019.
  • Case-control studies comparing circulating MMP levels in AAD patients and controls were included.
  • Standardized mean differences (SMDs) were calculated and pooled using a random-effects model.

Main Results:

  • Twelve studies with 458 AAD patients and 711 controls were analyzed.
  • Significantly elevated levels of MMP-8, MMP-9, and MMP-12 were observed in AAD patients compared to controls.
  • No significant differences in MMP-1, MMP-2, or MMP-3 levels were found between groups.

Conclusions:

  • Circulating MMP-9 levels are significantly associated with acute aortic dissection (AAD).
  • MMP-8 and MMP-12 may also be implicated in the pathophysiology of AAD.
  • These findings highlight potential roles for specific MMPs as biomarkers in AAD.